At the time of the article preparation, Mary Anne Powell was a student at the University of Alabama at Birmingham. Paul C. Erwin is an AJPH associate editor and is with the School of Public Health, University of Alabama at Birmingham. Pedro Mas Bermejo is with the Kourí Tropical Medicine Institute, Havana, Cuba.
Am J Public Health. 2021 Dec;111(12):2186-2193. doi: 10.2105/AJPH.2021.306526.
The purpose of this analytic essay is to contrast the COVID-19 responses in Cuba and the United States, and to understand the differences in outcomes between the 2 nations. With fundamental differences in health systems structure and organization, as well as in political philosophy and culture, it is not surprising that there are major differences in outcomes. The more coordinated, comprehensive response to COVID-19 in Cuba has resulted in significantly better outcomes compared with the United States. Through July 15, 2021, the US cumulative case rate is more than 4 times higher than Cuba's, while the death rate and excess death rate are both approximately 12 times higher in the United States. In addition to the large differences in cumulative case and death rates between United States and Cuba, the COVID-19 pandemic has unmasked serious underlying health inequities in the United States. The vaccine rollout presents its own set of challenges for both countries, and future studies can examine the comparative successes to identify effective strategies for distribution and administration. (. 2021;111(12):2186-2193. https://doi.org/10.2105/AJPH.2021.306526).
本文旨在对比古巴和美国在 COVID-19 疫情中的应对措施，并了解两国结果的差异。两国在卫生系统结构和组织以及政治理念和文化方面存在根本差异，因此结果存在重大差异也就不足为奇了。古巴对 COVID-19 的应对更加协调和全面，因此结果明显优于美国。截至 2021 年 7 月 15 日，美国的累计病例率比古巴高 4 倍以上，而死亡率和超额死亡率分别是古巴的 12 倍左右。除了美国和古巴之间的累计病例和死亡率存在巨大差异外，COVID-19 大流行还揭示了美国存在严重的潜在健康不平等问题。疫苗的推广对两国来说都提出了一系列挑战，未来的研究可以检查比较成功的案例，以确定有效的分配和管理策略。（2021；111（12）：2186-2193。https://doi.org/10.2105/AJPH.2021.306526）。
